1. Clinical significance of visceral pleural and lymphovascular invasion in surgically resected adenosquamous lung cancer. (17th November 2020) Authors: Wang, Yanan; Qian, Fangfei; Hu, Minjuan; Chen, Ya; Yang, Zhengyu; Han, Baohui Journal: European journal of cardio-thoracic surgery Issue: Volume 59:Number 3(2021) Page Start: 617 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Coexistence of sensitive and resistant epidermal growth factor receptor (EGFR) mutations in pretreatment non-small cell lung cancer (NSCLC) patients: First or third generation tyrosine kinase inhibitors (TKIs)?. (March 2018) Authors: Zhang, Bo; Xu, Jianlin; Zhang, Xueyan; Gu, Ping; Wang, Huimin; Wang, Shuyuan; Qian, Jie; Qiao, Rong; Zhang, Yanwei; Yang, Wenjia; Qian, Fangfei; Zhou, Yan; Lu, Jun; Zhang, Lele; Han, Baohui Journal: Lung cancer Issue: Volume 117(2018) Page Start: 27 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Combined large cell neuroendocrine carcinoma: clinical characteristics, prognosis and postoperative management. (11th February 2022) Authors: Yang, Zhengyu; Wang, Yanan; Chen, Ya; Qian, Fangfei; Zhang, Yanwei; Hu, Minjuan; Zhang, Wei; Han, Baohui Journal: European journal of cardio-thoracic surgery Issue: Volume 62:Number 2(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Community-based lung cancer screening with low-dose CT in China: Results of the baseline screening. (March 2018) Authors: Yang, Wenjia; Qian, Fangfei; Teng, Jiajun; Wang, Huimin; Manegold, Christian; Pilz, Lothar R.; Voigt, Weiland; Zhang, Yanwei; Ye, Jianding; Chen, Qunhui; Han, Baohui Journal: Lung cancer Issue: Volume 117(2018) Page Start: 20 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Complex epidermal growth factor receptor mutations and their responses to tyrosine kinase inhibitors in previously untreated advanced lung adenocarcinomas. Issue 11 (15th March 2018) Authors: Zhang, Bo; Wang, Shuyuan; Qian, Jie; Yang, Wenjia; Qian, Fangfei; Lu, Jun; Zhang, Yanwei; Qiao, Rong; Han, Baohui Journal: Cancer Issue: Volume 124:Issue 11(2018) Page Start: 2399 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Different clinical characteristics and survival between surgically resected pure and combined small cell lung cancer. Issue 19 (29th August 2022) Authors: Li, Yujing; Wang, Yanan; Zhou, Wensheng; Chen, Ya; Lou, Yuqing; Qian, Fangfei; Lu, Jun; Jiang, Haohua; Xiang, Biao; Zhang, Yanwei; Han, Baohui; Zhang, Wei Journal: Thoracic cancer Issue: Volume 13:Issue 19(2022) Page Start: 2711 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Local consolidative therapy for synchronous oligometastatic non‐small cell lung cancer treated with first‐line pembrolizumab: A retrospective observational study. Issue 5 (21st January 2022) Authors: Chen, Ya; Wang, Yanan; Yang, Zhengyu; Hu, Minjuan; Lu, Jun; Zhang, Yanwei; Qian, Fangfei; Zhang, Bo; Wang, Shuyuan; Wang, Kai; Zhang, Wei; Han, Baohui Journal: Thoracic cancer Issue: Volume 13:Issue 5(2022) Page Start: 732 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Safety and efficacy of anlotinib in combination with standard chemotherapy as first-line treatment for extensive-stage small cell lung cancer: A multi-center, prospective study (ACTION-2). (November 2022) Authors: Zhang, Wei; Deng, Pengbo; Kong, Tiandong; Zhang, Bo; Qian, Fangfei; Dong, Yu; Chen, Ya; Chen, Lu; Liu, Danna; Zhang, Yanwei; Yang, Huaping; Han, Baohui Journal: Lung cancer Issue: Volume 173(2022) Page Start: 43 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. The centromere-associated protein CENPU promotes cell proliferation, migration, and invasiveness in lung adenocarcinoma. (28th April 2022) Authors: Lou, Yuqing; Lu, Jun; Zhang, Yanwei; Gu, Ping; Wang, Huimin; Qian, Fangfei; Zhou, Wensheng; Zhang, Wei; Zhong, Hua; Han, Baohui Journal: Cancer letters Issue: Volume 532(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. The clinicopathological and molecular characteristics of resected EGFR‐mutant lung adenocarcinoma. (13th January 2022) Authors: Zhou, Wensheng; Liu, Zhichao; Wang, Yanan; Zhang, Yanwei; Qian, Fangfei; Lu, Jun; Wang, Huimin; Gu, Ping; Hu, Minjuan; Chen, Ya; Yang, Zhengyu; Zhao, Ruiying; Lou, Yuqing; Han, Baohui; Zhang, Wei Journal: Cancer medicine Issue: Volume 11:Number 5(2022) Page Start: 1299 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗